Show simple item record

dc.contributor.authorAsio, Santa Maria
dc.contributor.authorSimonsen, Paul E.
dc.contributor.authorOnapa, Ambrose W.
dc.date.accessioned2022-03-03T11:57:11Z
dc.date.available2022-03-03T11:57:11Z
dc.date.issued2009-03-01
dc.identifier.citationAsio, Santa Maria., Simonsen, Paul E., Ambrose W. Onapa (2009). Mansonella perstans filariasis in Uganda: patterns of microfilaraemia and clinical manifestations in two endemic communities. Oxford Academic: Transactions of The Royal Society of Tropical Medicine and Hygiene. https://doi.org/10.1016/j.trstmh.2008.08.007.en_US
dc.identifier.urihttps://doi.org/10.1016/j.trstmh.2008.08.007
dc.identifier.urihttps://kyuspace.kyu.ac.ug/xmlui/handle/20.500.12504/766
dc.description266–273 p.en_US
dc.description.abstractSurveys for Mansonella perstans infection and potentially related clinical manifestations were undertaken in two endemic communities in Mukono and Luwero districts of Uganda where no other human filarial infections are transmitted. A sensitive and accurate counting chamber method was used for quantifying microfilaraemia in 100 μl of finger-prick blood. Among 575 and 991 examined individuals aged ≥1 year in the two communities, the overall microfilariae (mf) prevalence was significantly higher in Mukono (76.5%) than in Luwero (57.7%). As early as age 1–4 years, 40.6% and 20.5% of the children were mf-positive. Prevalences increased rapidly with increasing age to reach 89.2% and 81.4% in the 15–19 years age group and then remained high in subsequent age groups. The geometric mean mf intensity among mf-positive individuals was slightly higher in the Mukono community (32.4 mf/100 μl) than in the Luwero community (29.9 mf/100 μl), and this parameter increased with age in both communities. No obvious associations were observed between various clinical parameters and M. perstans microfilaraemia in any of the study communities. The observed patterns of microfilaraemia and the lack of obvious visible clinical manifestations suggest that the host's regulatory responses are downregulated in M. perstans infections. [ClinicalTrials.gov identifier:en_US
dc.language.isoenen_US
dc.publisherOxford Academic: Transactions of The Royal Society of Tropical Medicine and Hygieneen_US
dc.relation.ispartofseriesVol.103;Issue 3
dc.subjectMansonella perstansen_US
dc.subjectFilariasisen_US
dc.subjectEpidemiologyen_US
dc.subjectMicrofilaraemiaen_US
dc.subjectMorbidityen_US
dc.subjectUgandaen_US
dc.titleMansonella perstans filariasis in Uganda: patterns of microfilaraemia and clinical manifestations in two endemic communitiesen_US
dc.typeArticleen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record